|
Jul 2
|
Here’s Why NeoGenomics (NEO) Sold Off in Q1
|
|
Jul 1
|
NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
|
|
Jun 30
|
NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
|
|
Jun 24
|
5 Insightful Analyst Questions From NeoGenomics’s Q1 Earnings Call
|
|
Jun 24
|
NeoGenomics Appoints Dr. Marjorie Green to Board of Directors
|
|
May 30
|
3 Volatile Stocks in Hot Water
|
|
May 28
|
NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
|
|
May 28
|
Firing on All Cylinders: Guardant Health (NASDAQ:GH) Q1 Earnings Lead the Way
|
|
May 23
|
NeoGenomics introduces c-MET companion diagnostic for NSCLC
|
|
May 22
|
NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
|
|
May 21
|
Envista, NeoGenomics, Acadia Healthcare, Astrana Health, and Hims & Hers Health Stocks Trade Down, What You Need To Know
|
|
May 9
|
Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares
|
|
Mar 14
|
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
|
|
Mar 12
|
3 Small-Cap Stocks in Hot Water
|
|
Mar 10
|
NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
|
|
Feb 24
|
NeoGenomics to Participate in Upcoming Investor Conferences
|
|
Feb 19
|
NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations
|
|
Feb 19
|
NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 19
|
Q4 2024 Neogenomics Inc Earnings Call
|
|
Feb 18
|
Why NeoGenomics (NEO) Shares Are Trading Lower Today
|